GeneHealth - Your precision medicine

Sarcocystosis

Disease Details

Family Health Simplified

Buy Membership

Description: Sarcocystosis is a parasitic disease caused by protozoa of the genus Sarcocystis, typically involving muscle and nervous system tissue in various animals, including humans.
Type: Sarcocystosis is a parasitic infection caused by protozoa of the genus Sarcocystis. It is not genetically transmitted. Sarcocystis parasites are typically acquired through the ingestion of contaminated food or water.
Signs And Symptoms: Signs and symptoms of sarcocystosis:

**Intestinal sarcocystosis:**
- Nausea
- Abdominal pain
- Diarrhea
- Sometimes asymptomatic

**Muscular sarcocystosis:**
- Muscle pain and tenderness
- Weakness
- Fever
- Swelling or lumps under the skin
- Eosinophilia (high number of eosinophils in the blood)

Severity can vary based on the individual's immune response and the form of sarcocystosis.
Prognosis: The prognosis for sarcocystosis varies depending on the form of the disease and the overall health of the affected individual. In general, intestinal sarcocystosis, which results from ingesting the sporocysts or oocysts, is usually self-limiting and has a good prognosis, with symptoms typically resolving on their own within a few days to weeks.

Muscular sarcocystosis, caused by the ingestion of sarcocysts in undercooked meat, may have a more prolonged course, with muscle pain and weakness that can persist for weeks to months. In most cases, the prognosis is still good, and patients recover fully over time, especially with supportive care and possibly anti-inflammatory medications.

In immunocompromised individuals, sarcocystosis may present more severe symptoms and a potential for complications, making the prognosis more guarded.

Overall, early diagnosis and supportive care generally lead to a favorable outcome for most individuals with sarcocystosis.
Onset: Sarcocystosis is a parasitic infection caused by protozoa of the genus Sarcocystis. The onset of symptoms can vary, typically manifesting within days to weeks after ingesting the infectious cysts through contaminated food or water. The severity and presentation of symptoms depend on whether the infection is intestinal or muscular. Intestinal infection may cause gastrointestinal symptoms like nausea, abdominal pain, and diarrhea, while muscular infection may result in muscle pain, swelling, and fever.
Prevalence: Sarcocystosis is a parasitic infection caused by the protozoan parasites of the genus Sarcocystis. The prevalence of sarcocystosis varies widely depending on geographic regions, sanitation conditions, and dietary habits. Specific prevalence data are limited; however, human sarcocystosis is generally considered rare, with most cases being reported in tropical and subtropical regions. In areas with poor sanitation and where raw or undercooked meat consumption is common, the prevalence can be higher. Detailed prevalence studies are often lacking, thus "nan" or "not available" can be an appropriate designation for specific prevalence statistics.
Epidemiology: Although human intestinal infection is common, extraintestinal human sarcocystosis is considered to be rare.The extremes of age reported to date are a 26-day-old infant and a 75-year-old man. Infections have been reported from Africa, Europe (Germany, Spain and Poland), the United States (California), Central and South America, China, India, Tibet, Malaysia, and Southeast Asia.Stool examinations in Thai laborers showed that Sarcocystis infection had a high prevalence of around 23%, reflecting ingestion of raw or undercooked meat. Virtually all cases appeared to be asymptomatic. A study of 100 human tongues obtained post mortem in Malaya revealed an infection rate of 21%. No sex difference was found and the age range was 16 to 57 years (mean 37.7 years).A non-enteric outbreak affecting 93 people was reported in 2012 in Malaysia. Sarcocystis nesbitti was confirmed to be the cause in several cases.
Intractability: Sarcocystosis, a parasitic infection caused by Sarcocystis species, is generally not considered intractable. The disease can typically be managed and treated effectively, especially when timely medical intervention is provided. Treatment often includes antiparasitic medications. However, the severity can vary, and in immunocompromised individuals, the condition might be more challenging to manage.
Disease Severity: Sarcocystosis: Disease Severity

Sarcocystosis is an infection caused by parasites of the genus Sarcocystis. The severity can vary significantly depending on the species involved and the host's immune status.

In humans, sarcocystosis can present in two forms:

1. **Intestinal Sarcocystosis**: Often asymptomatic or mild, but can cause gastrointestinal symptoms such as nausea, diarrhea, and abdominal pain. This form is generally not severe.

2. **Muscular Sarcocystosis**: More severe, leading to muscle pain, weakness, and, in some cases, muscle swelling or cyst formation. Symptoms can be prolonged and debilitating.

In animals, particularly livestock, sarcocystosis can range from asymptomatic to causing serious illness, impacting the health and productivity of the animal.
Healthcare Professionals: Disease Ontology ID - DOID:9640
Pathophysiology: Sarcocystosis is caused by protozoan parasites of the genus *Sarcocystis*. These parasites have a two-host life cycle, typically involving a prey-predator relationship. The definitive hosts are usually carnivores, such as dogs or humans, while the intermediate hosts are herbivores like cattle or pigs.

In the intermediate host, the ingested sporocysts release sporozoites that invade the intestinal epithelium and other tissues, developing into sarcocysts within muscle fibers. In the definitive host, consumption of contaminated meat containing sarcocysts leads to the release of bradyzoites, which invade the intestinal mucosa and develop into gamonts. Fertilization results in the formation of oocysts, which are released into the environment via feces, completing the cycle.

Human infection can occur by consuming undercooked meat containing sarcocysts (intestinal sarcocystosis) or by ingesting food or water contaminated with sporocysts (muscular sarcocystosis). Intestinal sarcocystosis may be asymptomatic or cause gastrointestinal symptoms, whereas muscular sarcocystosis can lead to myalgia, muscle weakness, and eosinophilia.
Carrier Status: Carrier status for sarcocystosis is not applicable (nan) because the disease is caused by protozoan parasites within the genus Sarcocystis, and it requires both a definitive host (where sexual reproduction occurs, often carnivores) and an intermediate host (where asexual reproduction occurs, typically herbivores or omnivores). Humans can be accidental intermediate hosts but cannot carry or transmit the disease as definitive hosts do.
Mechanism: Sarcocystosis is a disease caused by parasites of the genus Sarcocystis. Here's an overview of the mechanisms and molecular details:

### Mechanism:
1. **Transmission**: Humans can acquire sarcocystosis through ingestion of undercooked or raw meat containing sarcocysts or sporocysts. The life cycle typically involves an intermediate host (usually livestock) and a definitive host (often predators or humans).

2. **Life Cycle in Hosts**:
- **Intermediate Host**: Sarcocystis forms cysts in the muscles of intermediate hosts. These cysts contain bradyzoites, a type of parasite stage.
- **Definitive Host**: When a definitive host consumes contaminated meat, the bradyzoites are released in the intestines, where they invade the epithelial cells and reproduce sexually, producing sporocysts that are shed in feces, contaminating the environment.

3. **Human Disease**:
- **Intestinal Sarcocystosis**: Results from ingesting sporocysts. The parasites invade and multiply in the intestinal wall, leading to gastroenteritis-like symptoms.
- **Muscular Sarcocystosis**: Following ingestion of muscle cysts, the parasites can invade human muscle tissue, although this form is rare in humans.

### Molecular Mechanisms:
1. **Invasion and Development**:
- **Attachment and Invasion**: Surface proteins on Sarcocystis aid in attachment to and penetration of host cells.
- **Intracellular Survival**: Once inside the host cells, the parasites reside within vacuoles, where they undergo asexual reproduction, forming trophozoites that continue to multiply.

2. **Immune Evasion**:
- **Protein Modulation**: Sarcocystis can modify its surface proteins to evade the host immune system, allowing chronic infection.
- **Cyst Formation**: In intermediate hosts, the parasites form cysts that can remain dormant in muscle tissues, evading detection.

3. **Pathogenesis**:
- **Inflammatory Response**: The presence of parasites in the intestinal wall or muscle tissue triggers local inflammatory responses, leading to symptoms such as diarrhea, muscle pain, and sometimes systemic effects depending on the burden of infection.

Understanding these molecular mechanisms helps researchers develop targeted therapies and better diagnostic tools for managing sarcocystosis effectively.
Treatment: Current treatments are not entirely satisfactory. Amprolium (100 mg/kg, daily for 30 days), fed prophylactically, reduced illness in cattle inoculated with S. cruzi. Prophylactic administration of amprolium or salinomycin also protected experimentally infected sheep.
In horses, treatment has been confined to dihydrofolate reductase inhibitors such as the sulfonamides and pyrimethamine. Sulfadiazine (20 mg/kg orally) once or twice a day is a commonly used. Infected horses should also be placed on pyrimethamine at the dose of 1.0 mg/kg given once a day orally for 120 days or longer. Diclazuril and toltrazuril and other coccidiostats are being evaluated to treat EPM.
Compassionate Use Treatment: Sarcocystosis treatment primarily involves antiparasitic medications, though options for compassionate use or experimental treatments are limited due to the rarity of the disease. Off-label treatments may include:

1. **Antiparasitic Drugs:**
- **Trimethoprim-Sulfamethoxazole (TMP-SMX):** Commonly used off-label.
- **Pyrimethamine:** Sometimes used in combination with sulfadiazine.

2. **Corticosteroids:**
- Used to manage inflammatory responses in severe cases.

Experimental treatments may involve adapting protocols for similar parasitic diseases, but specific studies or trials are limited.

Medical professionals should tailor treatments based on individual patient conditions and emerging research.
Lifestyle Recommendations: For sarcocystosis, the following lifestyle recommendations might be helpful:

1. **Avoid Raw or Undercooked Meat**: Ensure that meat, especially pork and beef, is cooked thoroughly to kill any Sarcocystis parasites.

2. **Personal Hygiene**: Regular handwashing, especially after handling raw meat and before eating, can help reduce the risk of infection.

3. **Clean and Cook Vegetables**: Wash vegetables thoroughly and cook them when possible, as they might be contaminated with oocysts from animal feces.

4. **Safe Drinking Water**: Drink clean and treated water to avoid ingestion of oocysts that might be present in contaminated water sources.

5. **Proper Food Storage**: Store meat at appropriate temperatures to prevent the growth and spread of parasites.

6. **Avoid Feeding Raw Meat to Pets**: Pets can be carriers of the Sarcocystis parasite if they consume raw or undercooked meat. Feeding them cooked food helps prevent this.

7. **Travel Precautions**: When traveling to areas where Sarcocystis infection rates are higher, take extra precautions with food and water hygiene to prevent infection.

By following these lifestyle recommendations, the risk of acquiring sarcocystosis can be significantly reduced.
Medication: For sarcocystosis, treatment with antiparasitic medications such as trimethoprim-sulfamethoxazole (TMP-SMX) is commonly used. Other options may include pyrimethamine with sulfadiazine or clindamycin. Always consult with a healthcare provider for proper diagnosis and treatment.
Repurposable Drugs: Repurposing drugs for sarcocystosis, a parasitic disease caused by Sarcocystis species, mostly involves antiparasitic treatments commonly used for other parasitic infections. Some drugs that have shown potential include:

1. **Sulfadiazine** - Often used alongside pyrimethamine for parasitic infections.
2. **Trimethoprim-sulfamethoxazole (TMP-SMX)** - Commonly used against a variety of protozoal infections.

Research is ongoing to identify other effective treatments.
Metabolites: Sarcocystosis is a parasitic disease caused by protozoan parasites of the genus Sarcocystis. The specific metabolic pathways and metabolites involved in Sarcocystis infections are not well-characterized. Generally, like other protozoan parasites, they may rely on both host-derived nutrients and their own metabolic capabilities for survival and replication. Research in this area could provide more detailed insights into the parasite's metabolism and potential targets for treatment.
Nutraceuticals: For sarcocystosis, no specific nutraceuticals (dietary supplements or food products providing health benefits) are proven to treat or prevent the infection. The primary approach involves antiparasitic medication prescribed by a healthcare provider, along with supportive care to manage symptoms. Always consult a medical professional for appropriate diagnosis and treatment options.
Peptides: Sarcocystosis is a parasitic disease caused by protozoa of the genus Sarcocystis. Research into peptides and nanotechnology for Sarcocystosis is not widely developed. Current efforts focus on diagnostic techniques and treatment usually with antiparasitic drugs like sulfadiazine and trimethoprim-sulfamethoxazole. Peptide-based vaccines and nanotechnology could be future areas of study to improve prevention and treatment but are not yet common practice.